Exact Sciences Cancerguard Liquid Biopsy Test SEO Title

FOR IMMEDIATE RELEASE

Exact Sciences⁤ Launches Cancerguard, a Revolutionary Liquid Biopsy Test⁢ for ⁤Early Cancer Detection

Madison, WI – ⁤In a ⁢landmark move⁤ poised to redefine cancer screening, Exact Sciences has launched Cancerguard, a cutting-edge liquid⁣ biopsy test designed to detect signals⁤ for 50 different types of cancer. This innovative⁤ test is now available to ‍consumers, marking a⁢ meaningful leap forward in early cancer⁤ detection.

“I am feeling fantastic. ⁣This is what I came ⁣to Exact to do,” exclaimed⁢ Dr. Tom Beer, chief medical officer of Exact Sciences and a practicing ‍oncologist. Dr. ⁢Beer emphasized the profound impact of early cancer detection, a ⁢reality ⁤he witnesses ⁣weekly in ⁣his clinic. Cancerguard aims to⁢ extend this advantage to ⁢a broader range of cancers beyond the currently screened⁢ breast,prostate,colorectal,lung,and cervical cancers.

Cancerguard represents a paradigm shift⁢ in cancer screening. By analyzing a simple blood sample, the test can identify potential cancer signals, offering ⁢individuals and their healthcare ‍providers ‍a crucial head start in ⁢diagnosis and treatment.

“we are introducing a test, ‍but we ‍are really starting a new era in cancer early detection,” Dr. Beer stated. He envisions a future where screening for a multitude of ⁢cancers becomes the norm, a stark contrast to the limited screening practices of today. “It’s early days, but I think in 10 years,‍ when we look back on today, we ⁢won’t believe ⁣we used to only⁢ screen for a handful of cancers.”

about Exact Sciences

Exact Sciences is a leading ⁣biotechnology company‍ focused⁢ on developing innovative cancer screening and diagnostic tests. With a commitment to early detection, Exact Sciences aims to improve patient outcomes and ⁤transform the fight ⁢against ⁤cancer.

Contact:

[Insert contact Name]
[Insert Title]
[Insert email]
[Insert Phone Number]

###